Loading company…
Red Queen Bio develops AI-supported biosecurity technologies and medical countermeasures.
Red Queen Bio develops biosecurity technologies that combine AI models, laboratory automation, and reinforcement learning to design medical countermeasures. It works with frontier laboratories and targets government and biopharma stakeholders. The company is based in Boston, US. In November 2025, it raised USD 15 mn in Seed funding led by OpenAI, with participation from Cerberus Capital Management, Fifty Years, and Halcyon Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in